共 50 条
- [32] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease Digestive Diseases and Sciences, 2023, 68 : 4331 - 4338
- [34] A prospective analysis of body composition in patients with Inflammatory Bowel Disease and changes during biologic therapy JOURNAL OF CROHNS & COLITIS, 2022, 16 : I390 - I391
- [35] Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project JOURNAL OF CROHNS & COLITIS, 2020, 14 : S526 - S527
- [36] A prospective analysis of body composition in patients with Inflammatory Bowel Disease and changes during biologic therapy JOURNAL OF CROHNS & COLITIS, 2022, 16 : I390 - I391
- [39] Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S385 - S385